Mode
Text Size
Log in / Sign up
N/A N=40 Randomized Health Services Research

Combined Resistance and Aerobic Exercise Training on Obesity in Adolescent Girls

Obesity

Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Aug 2019
Primary outcome: Primary: Height in Meters — 1.58; 1.60 meters

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Combined Exercise Training (Behavioral)
Age
Pediatric · 14+ yrs
Sex
Female
Sponsor
Pusan National University
Primary completion
Jun 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Height in Meters
1.58; 1.60
PRIMARY
Weight in Kilograms
75.8; 70.2
PRIMARY
BMI in Weight (Kilograms)/Height (Meters)^2
30; 27
PRIMARY
Body Fat in Percents
43; 39.6
PRIMARY
Lean Body Mass in Percents
43; 39.6
PRIMARY
Waist Circumference in Centimeters
88.2; 83.5
PRIMARY
Glucose Levels in Millimole Per Liter
5.4; 4.3
PRIMARY
Insulin Levels in Micro Unit Per Milliliter
27; 10.3
PRIMARY
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
6.5; 1.9
PRIMARY
Leptin Levels in Nano Grams Per Milliliter
22.5; 12.8
PRIMARY
Adiponectin Levels in Micro Grams Per Milliliter
5.7; 8.5
SECONDARY
Volume of Maximal Oxygen Consumption (VO2max)
26; 27
SECONDARY
Arterial Stiffness
8.4; 8.4
SECONDARY
Systolic Blood Pressure
124; 120
SECONDARY
Diastolic Blood Pressure
80; 78
SECONDARY
Maximal Heart Rate
202; 202

Summary

The purpose of the study was to observe therapeutic effects of combined resistance and aerobic exercise training (CRAE) on hyperinsulemia in obese adolescent girls. Forty obese adolescent girls (14±1 years) participated in this study. The participants were randomly separated into two groups; no-exercise group (n=20) and exercise group (n=20). The exercise group performed 12 weeks of CRAE.

Eligibility Criteria

Inclusion Criteria

  • Obese with Hyperinsulinemia
  • Obese with Abdominal obesity

Exclusion Criteria

  • Hypertension
  • Pregnancy
  • Chronic diseases
  • Weight loss diet within the last 6 months
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03096873). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search